Product Safety Recalls

Product Recall Tracker

Recall D-0651-2024

Description: Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01

Recall D-0651-2024 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0651-2024
Event ID95190
DistributionNationwide in the USA
Quantity37 vials
Recall ReasonLack of Assurance of Sterility
Drug ClassificationClass II
Drug Code Info20240911
Recall Initiation Date20240822
Report Date20240911
Classification Date20240905
Address619 Jeffers Cir
Exton, PA 19341-2540
United States
Recalling FirmProRx LLC
Initial Notification Letter
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.